XXEC Inc
NVO icon

XXEC Inc’s Novo Nordisk NVO Stock Holding History

XXEC Inc’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.63M Sell
69,477
-760,911
-92% -$35.1M 3.67% 14
2026
Q2 		$37.3M Buy
830,388
+285,368
+52% +$12.3M 4.85% 11
2026
Q1 		$29M Buy
545,020
+452,185
+487% +$21.4M 5.08% 10
2025
Q4 		$4.72M Sell
92,835
-6,240
-6% -$319K 4.72% 11
2025
Q3 		$5.5M Buy
99,075
+20,890
+27% +$1.22M 4.64% 10
2025
Q2 		$5.4M Buy
78,185
+21,756
+39% +$1.48M 4.34% 11
2025
Q1 		$3.92M Buy
56,429
+38,102
+208% +$3.15M 3.4% 13
2024
Q4 		$1.58M Buy
+18,327
New +$1.98M 1.31% 21

Other funds holding NVO

Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Everett Harris & Co
Everett Harris & Co Los Angeles, California $8.46B AUM 13.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Saratoga Research & Investment Management
Saratoga Research & Investment Management Saratoga, California $1.82B AUM 11.8% 1-Year Est. Return
Markel Group
Markel Group Glen Allen, Virginia $12.8B AUM 8.77% 1-Year Est. Return
Natixis
Natixis Paris, France $28B AUM 27.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

XXEC Inc's NVO Position: Q3 2026 in Review

XXEC Inc reduced its Novo Nordisk (NVO) stake by 92% in Q3 2026, selling an estimated $35.1M and leaving 69,477 shares worth $2.63M. The position accounts for 3.67% of the portfolio, ranked #14.

XXEC Inc first reported a position in NVO in Q4 2024 and has held it in 8 quarters since. The position peaked at $37.3M in Q2 2026. 816 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • XXEC Inc held 69,477 shares of Novo Nordisk worth $2.63M as of Q3 2026.
  • XXEC Inc sold 760,911 Novo Nordisk shares in Q3 2026, an estimated $35.1M.
  • Novo Nordisk made up 3.67% of XXEC Inc's portfolio in Q3 2026, its #14 holding.
  • XXEC Inc first reported a position in Novo Nordisk in Q4 2024 and has held it in 8 quarters since.
  • XXEC Inc's Novo Nordisk position peaked at $37.3M in Q2 2026.
  • 816 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on XXEC Inc's 13F filing for Q3 2026, filed 5 Nov 2026.